ampicillin has been researched along with cefoperazone in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (31.15) | 18.7374 |
1990's | 15 (24.59) | 18.2507 |
2000's | 17 (27.87) | 29.6817 |
2010's | 10 (16.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
Kwon, DH; Lu, CD | 1 |
Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ng, NK; Sivalingam, N | 1 |
Livermore, DM | 1 |
Atabey, N; Gökoğlu, M | 1 |
Ayers, OM; Everett, BQ; Hill, GB | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
Deguchi, K; Fukayama, S; Fukushima, Y; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Barry, AL; Jones, RN | 1 |
Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Alicea, M; Colucci, RD; Greenstein, R; Halpern, NA | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Ito, T; Tamura, M | 1 |
Bergeron, MG; Biron, S; Chan, R; Feld, R; Fong, IW; Harding, GK; Mandell, L; Mendelson, J; Rachlis, A; Segal, NB | 1 |
Doty, JE; Manchester, B; Mann, LL; Muller, EL; Pitt, HA; Thompson, JE | 1 |
Bergeron, MG; Provencher, P; Simard, P | 1 |
Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
Brun, Y; Brune, J; Ros, A; Vergnon, JM; Vincent, M | 1 |
Homberger, F; Kayser, FH; Morenzoni, G | 1 |
Alliegro, GM; Brodeur, JP; Sande, MA; Scheld, WM | 1 |
Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Foulds, G; Hayes, SL; Marshall, DC; McMahon, FG; O'Brien, MM; Stankewich, JP; Weidler, DJ | 1 |
Reddy, J | 1 |
Andrews, JM; Bedford, KA; Wise, R | 1 |
Hayashi, T; Kitayama, R; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
Matsuda, S | 1 |
Matsubara, N; Minami, S; Mitsuhashi, S; Saikawa, I; Watanabe, Y; Yasuda, T; Yotsuji, A | 1 |
Ansolis, LE; Budanov, SV; Kuleshov, SE; Navashin, SM; Rezvan, SP; Sidorenko, SV; Speranskaia, ON; Tikhonova, As; Tsvigun, EA | 1 |
Budanov, SV; Rezvan, SP; Sidorenko, SV | 1 |
Ansolis, LE; Budanov, SV; Krotova, LA; Kuleshov, SE; Navashin, SM; Rezvan, SP; Sidorenko, SV; Speranskaia, ON; Strachunskiĭ, LS; Tikhonova, AS | 1 |
Baker, M; Chang, Y; Danko, LS; Greenberg, RN; Meade, DW | 1 |
Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Filatov, LB; Iarikova, EN; Isaev, VG; Kaletin, GI; Kaporskaia, TS; Kliasova, GA; Klimko, NN; Lapin, VA; Medvedeva, NV; Parovichnikova, EN; Porokhona, ON; Pristupa, AS; Rekhtman, GB; Rossiev, VA; Savchenko, VG; Sharov, LN; Tolkacheva, TV; Tumakov, VA | 1 |
Kaya, O; Kirkan, S; Unal, B | 1 |
Alaeddinoglu, NG; Gürsel, I; Hasirci, V; Korkusuz, F; Türesin, F | 1 |
Gürsel, I; Hasirci, V; Türesin, F | 1 |
Büyükokuroğlu, ME; Ciftçi, M; Küfrevioğlu, OI | 1 |
Levin, AS | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Mumladze, MR; Oboladze, ED; Sukoyan, GV; Varazanashvili, NA | 1 |
Chen, SH; Huang, YC; Lee, AR; Lee, CW; Tsou, TL; Wang, HJ | 1 |
Akova, M | 1 |
Kim, YG; Núñez, G; Shibuya, A; Totsuka, N; Udayanga, KG; Weinberg, JB | 1 |
Bell, RL; Boddu, SH; Goodwani, S; Rao, PS; Sari, Y; Wei, Y | 1 |
Fujimori, N; Horiuchi, K; Joshita, S; Kasuga, E; Komatsu, M; Matsumoto, A; Sugiura, A; Tanaka, E; Umemura, T; Yamazaki, T | 1 |
5 review(s) available for ampicillin and cefoperazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1987 |
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulbactam | 2002 |
Sulbactam-containing beta-lactamase inhibitor combinations.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam | 2008 |
A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
Topics: Aged; Ampicillin; Cefoperazone; Coinfection; Desulfovibrio desulfuricans; Desulfovibrionaceae Infections; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Liver Abscess; Meropenem; Thienamycins | 2018 |
7 trial(s) available for ampicillin and cefoperazone
Article | Year |
---|---|
The role of prophylactic antibiotics in caesarean section--a randomised trial.
Topics: Ampicillin; Cefoperazone; Cesarean Section; Emergencies; Female; Humans; Pregnancy; Premedication; Prospective Studies; Surgical Wound Infection | 1992 |
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards.
Topics: Amoxicillin; Ampicillin; Bacteria, Anaerobic; Cefmetazole; Cefoperazone; Microbial Sensitivity Tests; Multicenter Studies as Topic; Quality Control; Ticarcillin | 1989 |
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Biliary Tract Diseases; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Tobramycin | 1988 |
Antibiotics in infections of the biliary tract.
Topics: Ampicillin; Bacterial Infections; Cefoperazone; Cholangitis; Cholecystitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1987 |
[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology].
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pleurisy; Pneumonia; Random Allocation; Time Factors; Tobramycin | 1985 |
Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Cefoperazone; Cefotaxime; Clinical Trials as Topic; Cloxacillin; Female; Gentamicins; Humans; Male; Middle Aged; Random Allocation; Ticarcillin; Vitamin K | 1984 |
[The empirical antibiotic therapy of patients with acute leukemias: the results of a multicenter study].
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Gentamicins; Humans; Leukemia; Russia; Sulbactam; Time Factors; Ukraine | 1998 |
49 other study(ies) available for ampicillin and cefoperazone
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
Topics: Ampicillin; beta-Lactamases; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Sulbactam | 1992 |
[The effect of some antibiotics on primary antibody response].
Topics: Ampicillin; Animals; Antibody Formation; Cefoperazone; Drug Therapy, Combination; Mezlocillin; Rabbits; Rifamycins; Sulbactam | 1991 |
Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
Topics: Ampicillin; Anti-Bacterial Agents; Antiprotozoal Agents; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Topics: Ampicillin; Ampicillin Resistance; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Penicillin Resistance; Sulbactam | 1990 |
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
Topics: Ampicillin; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Oxacillin; Sodium Chloride; Staphylococcus; Sulbactam | 1990 |
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Topics: Ampicillin; Cefoperazone; Chemistry, Pharmaceutical; Drug Incompatibility; Humans; Infusions, Intravenous; Intensive Care Units; Nicardipine; Sulbactam | 1989 |
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin | 1986 |
Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Chloramphenicol; Culture Media; Drug Combinations; Erythromycin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.
Topics: Ampicillin; Bacteria; beta-Lactamases; Cefoperazone; Cephalosporins; Conjugation, Genetic; Culture Media; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Time Factors | 1982 |
Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Chloramphenicol; Gentamicins; Meningitis; Penicillins; Rabbits | 1982 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Pharmacokinetics of sulbactam in humans.
Topics: Adult; Ampicillin; Cefoperazone; Cephalosporins; Drug Combinations; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Penicillanic Acid; Penicillin G; Sulbactam | 1983 |
Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
Topics: Ampicillin; Bacteria; Cefoperazone; Cefotiam; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Penicillins | 1981 |
Studies on protein binding of antibiotics. II. Effect of apalcillin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
Topics: Ampicillin; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cephalosporins; Drug Interactions; Humans; Male; Naphthyridines; Protein Binding; Rabbits; Serum Albumin | 1981 |
[A study of the analysis of urinary excretion of antimicrobial agents and the prediction of their urinary level in patients].
Topics: Ampicillin; Cefoperazone; Gentamicins; Humans; Kinetics; Models, Biological; Time Factors | 1984 |
Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporinase; Cloxacillin; Drug Interactions; Enterobacter; Enterobacteriaceae | 1983 |
[Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
Topics: Ampicillin; Cefoperazone; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; Sulbactam | 1995 |
[Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Topics: Ampicillin; Bacteria, Anaerobic; Cefoperazone; Cefoxitin; Drug Combinations; Drug Resistance, Microbial; Imipenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam | 1995 |
[Comparative in vitro activity ampicillin, cefoperazone, their combinations with sulbactam, as well as that of other antibiotics against aerobic gram-negative microorganisms].
Topics: Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1994 |
In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
Topics: Ampicillin; Bacteria; Cefoperazone; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam; Time Factors | 1993 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
Isolation of Dermatophilus congolensis from a cat.
Topics: Actinomycetales; Actinomycetales Infections; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cefoperazone; Cephalosporins; Dermatitis; Gentamicins; Oxytetracycline; Penicillins; Rabbits; Skin Diseases, Bacterial; Streptomycin | 2000 |
In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis.
Topics: Absorbable Implants; Ampicillin; Animals; Cefoperazone; Drug Carriers; Drug Combinations; Humans; Hydroxybutyrates; Osteomyelitis; Polyesters; Prostheses and Implants; Prosthesis Implantation; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tibia | 2001 |
Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release.
Topics: Ampicillin; Anti-Bacterial Agents; Biocompatible Materials; Cefoperazone; Drug Combinations; Drug Implants; Humans; Hydroxybutyrates; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Osteomyelitis; Polyesters; Sulbactam | 2001 |
Effect of cefaperazone/sulbactam and ampicillin/sulbactam on the in vitro activity of human erythrocyte glucose-6-phosphate dehydrogenase.
Topics: Ammonium Sulfate; Ampicillin; Blood Proteins; Cefoperazone; Chromatography, Affinity; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Glucosephosphate Dehydrogenase; Hemolysis; Humans; In Vitro Techniques; Kinetics; Sulbactam | 2001 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
In vitro effects of gentamicin, ampicillin, and cefobid on energy supply and antioxidant protection systems of venous blood erythrocytes in newborns.
Topics: Adenosine Triphosphate; Ampicillin; Anti-Bacterial Agents; Antioxidants; Catalase; Cefoperazone; Energy Metabolism; Erythrocytes; Gentamicins; Glutathione Peroxidase; Glutathione Reductase; Humans; Hydrogen Peroxide; Infant, Newborn; Reactive Oxygen Species | 2005 |
Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with beta-cyclodextrin stationary phase.
Topics: Ampicillin; beta-Cyclodextrins; Cefoperazone; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Drug Combinations; Glucose; Methanol; Models, Chemical; Reproducibility of Results; Sulbactam; Temperature | 2007 |
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.
Topics: Adoptive Transfer; Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Candida; Candidiasis; Cefoperazone; Celecoxib; Clindamycin; Cyclooxygenase Inhibitors; Dinoprostone; Dysbiosis; Feces; Gastrointestinal Tract; Inflammation; Lung; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; Sulfonamides | 2014 |
Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.
Topics: Alcohol Drinking; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Ampicillin; Animals; Anti-Bacterial Agents; Body Weight; Cefazolin; Cefoperazone; Central Nervous System Depressants; Conditioning, Operant; Drinking; Ethanol; Excitatory Amino Acid Transporter 2; Food Preferences; Male; Mitochondria; Mitochondrial Proteins; Nucleus Accumbens; Oncogene Protein v-akt; Prefrontal Cortex; Rats; Sucrose; Sweetening Agents; Time Factors | 2015 |